Lifereal Biotechnology Received Millions of Dollars in Financing From Huagai Capital

On May 31, 2019, Lifereal Biotechnology just received millions of dollars in Series A financing that was led by Hugai Capital.

Founded in September 2011, Lifereal Biotechnology has been focusing on the development and production of life sciences and clinical diagnostic products. The company has completed the development of a series of fully automatic integrated molecular diagnostic equipment and is committed to providing customers with cost-effective clinical diagnostic products.

Founder of Lifereal Biotechnology Mr. Huai Zhao, said "I am very grateful to Huagai Capital for trusting in the team of Lifereal Biotechnology. The prospects for the application of molecular diagnostic products in China are very good, and there are still many fields that have not been fully developed. We are willing to work with the other organizations to improve molecular diagnostic products in China".

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.